Prognosis and Follow-Up of Idiopathic Pulmonary Fibrosis
AbstractIdiopathic pulmonary fibrosis (IPF), a devastating progressive interstitial lung disease (ILD) with no known cause, is the most common and deadly of the idiopathic interstitial pneumonias. With a median survival of 3–5 years following diagnosis, IPF is characterized by a progressive decline in lung function and quality of life in most patients. Prognostic factors recognized classically that influence mortality include functional, clinical and radiological parameters. However, in recent years, there has also been progress in the knowledge of genetic factors and biomarkers that may be useful in the prognostic evaluation of these patients. On the other hand, the monitoring of the disease throughout its evolution is key to improving the prognosis of the patients, as it allows for taking therapeutic measures based on this evolution, even early remission for lung transplantation. This article reviews the main prognostic factors of the disease, as well as the most useful way to monitor the disease follow-up. View Full-Text
Share & Cite This Article
Fernández Fabrellas, E.; Peris Sánchez, R.; Sabater Abad, C.; Juan Samper, G. Prognosis and Follow-Up of Idiopathic Pulmonary Fibrosis. Med. Sci. 2018, 6, 51.
Fernández Fabrellas E, Peris Sánchez R, Sabater Abad C, Juan Samper G. Prognosis and Follow-Up of Idiopathic Pulmonary Fibrosis. Medical Sciences. 2018; 6(2):51.Chicago/Turabian Style
Fernández Fabrellas, Estrella; Peris Sánchez, Ricardo; Sabater Abad, Cristina; Juan Samper, Gustavo. 2018. "Prognosis and Follow-Up of Idiopathic Pulmonary Fibrosis." Med. Sci. 6, no. 2: 51.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.